Previously, we showed that intraperitoneal (IP) administration of NCT reversed hepatic steatosis in obese mice fed a high fat diet (HFD) through a previously unsuspected pathway involving regulation by HNF4α of dihydroceramide synthesis. The gene discussed is HNF4A; the disease is fatty liver disease.